Autopsy report · NCT00314002
Catheter Thrombectomy in Patients With Massive Pulmonary Embolism
Cause of deathOther
“After treatment of 7 patients, it was decided that the handling characteristics of the test device should be upgraded before continuing the trial as planned.”
Life of this trial
- Registered 6 months after it had already started.
- Ran for about 1 year 6 months before it stopped.
- 50 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Straub Medical AG
- Sponsor type
- Industry
- Conditions
- Pulmonary Embolism
- Interventions
- Mechanical Thrombectomy
- Participants
- 50 (planned, not actual)
- Sites
- 5
- Countries
- Germany, Switzerland
Trials that died the same way
- A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma
“Replaced with another clinical trial.” - Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism
“Decision to change trial design.” - Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies
“6 patients were recuited. Due to inability of the tracer to detect regions of interest sufficiently, the trial was closed early.” - Continuous Glucose Monitoring (POC) in the ICU
“Study device required infeasible modifications. No patients received device.” - Optimized Caloric-proteic Nutrition in Septic and Septic Shock Patients
“The protocol was modified substantially and will be resubmitted to Clinical Trial”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.